Albendazole

Active ingredient description

Αlbendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
P02CA03
Albendazole
P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Medicines

Albendazole is the active ingredient of these drugs:

Drug
Countries
ADAZOL

Ecuador

ALBEL

Brazil

ALBENDOL

Singapore

ALBENSTAR

Ecuador

ALBENTEL

Brazil

ALBENZA

Estonia United States

ALBENZOL

Ecuador

ALZENTAL

Singapore

ANDAZOL

Estonia Lithuania

ASCAROL

Ecuador

AVIR

Ecuador

BENDEX

South Africa

BENZATEL

Ecuador

ESKAZOLE

Australia Austria Estonia France Lithuania

FAGOL

Ecuador

HELMINTOL

Ecuador

ITALBENZOL

Ecuador

LONDAZOL

Ecuador

LUPIBEND

Lithuania

MEBENIX

Brazil

MONOZOL

Brazil

NEMACEST

Tunisia

NUBEND

South Africa

PARANTHIL

South Africa

PARASIN

Brazil

ROTOPAR

Ecuador

TENNIAL

Ecuador

VERMIGEN

Ecuador

VERMILIFE

Ecuador

WORMADOLE

South Africa

Z ZOLE

Tunisia

ZENDIS

Tunisia

ZENTEL

Australia Ecuador France Poland Singapore

ZESTAVAL

Cyprus

ZOLBEN

Brazil

Albendazole is also found within below combination drugs:

ASCARAMEB , PARASI-KIT , PARASIPACK , PAZIDOL 1-2 , PROTHELMINT

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 265.331 g/mol

External identifiers

CAS Substance: 54965-21-8
DrugBank Drug: DB00518
KEGG Drug: D00134
RxNorm Ingredient: 430
SNOMED-CT Concept: 387558006
Albendazole (substance)
UNII Identifier: F4216019LN
ALBENDAZOLE
 
Next: Usage >